Strong data from previous NGAL study provides the basis for new protocol and FDA registration application

in General IT, Industry News / by / on July 14, 2017 at 5:05 am /

(Source: GlobeNewswire (press release)) Strong data from previous NGAL study provides the basis for new protocol and FDA … the validation data for BioPorto’s FDA application for The NGAL Test™.

Open this article in new window